AK Steel (AKS - Get Report) was upgraded to buy from underperform at Bank of America/Merrill Lynch. $8 price target. Earnings estimates have also increased, given cost-cutting and a focus on premium products, analysts said.
AthenaHealth (ATHN was downgraded to equal-weight from overweight at Morgan Stanley. $117 price target. Business transition is impacting revenue growth, Morgan said.
CR Bard (BCR was upgraded to outperform from market perform at BMO Capital. The valuation is more attractive, based on a $240 price target, BMO said.
Baker Hughes (BHI was upgraded to outperform from market perform at Cowen. $65 price target. The company is trading at a discount to its peers and can continue to cut costs, Cowen said.
Lowe's was downgraded to neutral from outperform at Wedbush. $73 price target. The housing cycle has likely already seen its best days, Wedbush said.
Pandora (P was downgraded to underweight from overweight at Albert Fried. $8 price target. The company is facing increased operating costs and competition.
Team Health (TMH was downgraded to market perform at Leerink Partners. $43 price target. The company is facing operating challenges and is already factoring in a potential takeover, Leerink said.
Under Armour (UA - Get Report) was downgraded to hold at Deutsche Bank. $32 price target. Profit is being hurt by future investments and the company is valued at 48x expected 2017 earnings, Deutsche said.